SCHEMBL17286129

SCHEMBL17286129

Cc1cc(C(=O)CN(C)C2CCC(N(C)C)CC2)c(C)n1-c1ccc(N)cc1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.45
HTT P42858 4/20 0.45
ALDH1A1 P00352 4/20 0.45
MITF O75030 3/20 0.45
MAPT P10636 3/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
HKDC1 Q2TB90 2/20 0.45
SMN1; SMN2 Q16637 6/20 0.44
NPC1 O15118 3/20 0.44
USP14 P54578 9/20 0.43
LMNA P02545 3/20 0.43
HPGD P15428 3/20 0.43
USP7 Q93009 3/20 0.42
KDM4E B2RXH2 2/20 0.42
USP5 P45974 2/20 0.42
POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6922931 0.92 USP14 (0.49) RAB9AHTTALDH1A1MEN1KMT2A
SCHEMBL6923190 0.89 USP14 (0.47) RAB9AHTTALDH1A1MITFMAPT
SCHEMBL6921573 0.83 SMN1; SMN2 (0.62) RAB9AHTTMAPTMEN1KMT2A
SCHEMBL17286128 0.83 USP14 (0.44) RAB9AHTTALDH1A1MITFMAPT
SCHEMBL19501342 0.83 SMN1; SMN2 (0.60) RAB9AHTTALDH1A1MEN1KMT2A
SCHEMBL6923276 0.82 ALDH1A1 (0.50) RAB9AHTTALDH1A1MITFMAPT
SCHEMBL19749200 0.81 USP14 (0.49) RAB9AHTTALDH1A1MEN1KMT2A
SCHEMBL17949746 0.81 USP14 (0.61) RAB9AHTTALDH1A1MITFMAPT
SCHEMBL19501673 0.81 HTT (0.49) RAB9AHTTALDH1A1MITFMAPT
SCHEMBL17949717 0.79 MAPK1 (0.53) RAB9AHTTALDH1A1MITFMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150335652-A1 USP14 Inhibitors for Treating or Preventing Viral Infections PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2015-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150335652-A1 USP14 Inhibitors for Treating or Preventing Viral Infections USP14, USP1, USP13 RAB9A 1746/4885HTT 3270/4885ALDH1A1 1697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.